Skip to Main Content

Paper Details

Development and Characterization of Novel Endoxifen-Resistant Breast Cancer Cell Lines Highlight Numerous Differences from Tamoxifen-Resistant Models.
Mol Cancer Res
2
2021

Datasets

Release 1.2